| CLINICAL STUDY | Phase I |
| INDICATION'S |
- Melanoma - neuroblastoma |
| MECHANISM OF ACTION | Immunocytokine targeting GD2 |
| COMPANY | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
| PATENT ASSIGNEE | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |